Attovia Therapeutics, Inc. ATTO
16.73 USD +0.09 (+0.54%)
At closeNov 11, 2026, 4:00 PM EST
16.73 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
16.44 Day range 17.37
12.94 52-week range 28.00
- YTD
- -23.61%
- 1 year
- -23.61%
News
benzinga.com Citigroup Maintains Buy on Attovia Therapeutics, Raises Price Target to $34 Citigroup analyst Yigal Nochomovitz maintains Attovia Therapeutics (NASDAQ:ATTO) with a Buy and raises the price target from $30 to $34.
benzinga.com Morgan Stanley Maintains Overweight on Attovia Therapeutics, Raises Price Target to $40 Morgan Stanley analyst Judah Frommer maintains Attovia Therapeutics (NASDAQ:ATTO) with a Overweight and raises the price target from $39 to $40.
seekingalpha.com Attovia Therapeutics, Inc. (ATTO) Discusses ATTO-1310 Phase Ib Results in Chronic Pruritus and Atopic Dermatitis Transcript Attovia Therapeutics, Inc. (ATTO) Discusses ATTO-1310 Phase Ib Results in Chronic Pruritus and Atopic Dermatitis Transcript
benzinga.com Attovia Therapeutics Q3 EPS $(0.76) Misses $(0.50) Estimate Attovia Therapeutics (NASDAQ:ATTO) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.50) by 52 percent. This is a 77.91 percent increase over losses of…
globenewswire.com Attovia Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update Announced positive topline 12-week Phase 1b results for ATTO-1310 in patients with chronic pruritus (CP) and high-itch atopic dermatitis (AD) Initiation of global Phase 2 trials of ATTO-1310 in…
marketbeat.com Attovia Therapeutics Reports Sustained Itch Relief in Small Study, Plans Phase 2 Trials Attovia Therapeutics NASDAQ: ATTO reported 12-week results from a small phase 1b study of its experimental itch treatment ATTO-1310, saying a single dose produced sustained responses in patients with…
globenewswire.com Attovia Therapeutics Announces Positive Topline 12-Week Results from Phase 1b Study of ATTO-1310 in Patients with Chronic Pruritus and High-Itch Atopic Dermatitis Results build on preliminary Week 4 findings, in which a single dose of ATTO-1310 demonstrated rapid, deep, and durable itch relief in patients with chronic pruritus (CP) and high-itch atopic…
globenewswire.com Attovia Therapeutics to Participate in Upcoming Investor Conferences SAN CARLOS, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia” or the “Company”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation…- benzinga.com Attovia Therapeutics To Present New Clinical, Translational, And Preclinical Data Across Its Pipeline At EADV Congress And FCD 2026 Attovia Therapeutics, Inc. ("Attovia") (NASDAQ:ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today…
globenewswire.com Attovia Therapeutics to Present New Data on ATTO-1310 and ATTO-2306 at EADV 2026 and Fall Clinical Dermatology Conference 2026 SAN CARLOS, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for…
seekingalpha.com Attovia Therapeutics, Inc. (ATTO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Attovia Therapeutics, Inc. (ATTO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
benzinga.com Quanex Building Products, Concrete Pumping, SanDisk And Other Big Stocks Moving Higher On Friday U.S. stocks mostly fell, but Quanex surged 16.6% after beating earnings and sales estimates; Reading, BBCP, Astera Labs and others also gained.
globenewswire.com Attovia Therapeutics to Participate in Upcoming Investor Conferences SAN CARLOS, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia” or the “Company”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation…
benzinga.com Attovia Therapeutics Q2 EPS $(4.88) Misses $(4.62) Estimate, Sales $450.000K Attovia Therapeutics (NASDAQ:ATTO) reported quarterly losses of $(4.88) per share which missed the analyst consensus estimate of $(4.62) by 5.63 percent. This is a 31.54 percent decrease over losses…
globenewswire.com Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update ATTO-1310 demonstrated preliminary clinical proof of concept in chronic pruritus and high-itch atopic dermatitis (AD); complete Phase 1b data expected in Q4 2026- benzinga.com Citigroup Initiates Coverage On Attovia Therapeutics with Buy Rating, Announces Price Target of $30 Citigroup analyst Yigal Nochomovitz initiates coverage on Attovia Therapeutics (NASDAQ:ATTO) with a Buy rating and announces Price Target of $30.
benzinga.com LifeSci Capital Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $45 LifeSci Capital initiates coverage on Attovia Therapeutics (NASDAQ:ATTO) with a Outperform rating and announces Price Target of $45.- benzinga.com Leerink Partners Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $52 Leerink Partners analyst Thomas Smith initiates coverage on Attovia Therapeutics (NASDAQ:ATTO) with a Outperform rating and announces Price Target of $52.
benzinga.com RBC Capital Initiates Coverage On Attovia Therapeutics with Outperform Rating, Announces Price Target of $45 RBC Capital analyst Brian Abrahams initiates coverage on Attovia Therapeutics (NASDAQ:ATTO) with a Outperform rating and announces Price Target of $45.
247wallst.com Here Are Monday’s Top Wall Street Analyst Research Calls: AGCO Corporation, Deere & Co., Edison International, Lumentum Holdings, PG&E, Sempra Energy, STAG Industrial, Ticketplus, and More Rate hike fears rattled markets heading into the Labor Day weekend, and Wall Street analysts responded with a flurry of bold calls on utilities, farm equipment giants, and a ticketing upstart that…
benzinga.com This Lumentum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…
benzinga.com Morgan Stanley Initiates Coverage On Attovia Therapeutics with Overweight Rating, Announces Price Target of $39 Morgan Stanley analyst Judah Frommer initiates coverage on Attovia Therapeutics (NASDAQ:ATTO) with a Overweight rating and announces Price Target of $39.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 50.7% to $3.27 during Thursday's after-market session. The market value of their outstanding shares is at $1.6 million. Modular Medical (NASDAQ:MODD)…
247wallst.com Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source Attovia Therapeutics (NASDAQ:ATTO) has arrived on public markets with a pipeline built entirely on one bet: that a biparatopic antibody platform called Attobody can turn well-validated immunology…
defenseworld.net Attovia Therapeutics (NASDAQ:ATTO) Director Acquires $1,785,000.00 in Stock Attovia Therapeutics, Inc. (NASDAQ: ATTO - Get Free Report) Director Colin Walsh purchased 85,000 shares of the firm's stock in a transaction dated Wednesday, August 5th. The stock was bought at an…
defenseworld.net Attovia Therapeutics (NASDAQ:ATTO) Major Shareholder Global Strategic Fund Venbio Purchases 382,352 Shares of Stock Attovia Therapeutics, Inc. (NASDAQ: ATTO - Get Free Report) major shareholder Global Strategic Fund Venbio purchased 382,352 shares of the business's stock in a transaction that occurred on Thursday,…
defenseworld.net Attovia Therapeutics (NASDAQ:ATTO) Major Shareholder Redmile Group, Llc Purchases 200,000 Shares Attovia Therapeutics, Inc. (NASDAQ: ATTO - Get Free Report) major shareholder Redmile Group, Llc bought 200,000 shares of Attovia Therapeutics stock in a transaction on Thursday, August 6th. The…
globenewswire.com Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares SAN CARLOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for…
prnewswire.com Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5,…
globenewswire.com Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering SAN CARLOS, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for…
globenewswire.com Attovia Therapeutics Appoints John W. Smither to Board of Directors Mr. Smither brings extensive public company board and audit committee experience in the biotechnology sector Mr. Smither brings extensive public company board and audit committee experience in the…- benzinga.com NYSE To Commence Delisting Proceedings Against Atento S.A. The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares of Atento S.A. (the
benzinga.com Why Nocera Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket Gainers Nocera, Inc. (NASDAQ: NCRA) shares surged 88.7% to $5.17 in pre-market trading after the company announced plans to acquire Zhe Jiang Xin Shui Hu Digital Information, Ltd.- benzinga.com Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Session Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share.
benzinga.com Nasdaq Edges Lower; ISM Manufacturing PMI Drops In June U.S. stocks traded mixed midway through trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.16% to 34,462.62 while the NASDAQ fell 0.03% to 13,784.02. The S&P 500, also…- benzinga.com Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.
benzinga.com Watching Atento S.A.; Stock Price Moving Higher As Traders Circulate Co Website, Mentioned As AI-Related In The Cyber Security Space; Shares Up 100% https://atento.com/en/next-generation-capabilities/ai-cognitive/- benzinga.com Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter…
- benzinga.com Stocks That Hit 52-Week Lows On Thursday Thursday's session saw 189 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 100 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's morning session saw 84 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 497 companies set new 52-week lows.
- benzinga.com Atento S.A. Entered Into Financing Arrangements On February 15, 2023 With A Group Of Certain Existing Investors In Atento To Provide Additional Financing; The Total Capital Raised Is ~$40M Atento S.A. (NYSE:ATTO, &, ldquo, Atento&, rdquo, )))) entered into financing arrangements on February 15, 2023 with a group of certain existing investors in Atento to provide additional financing to…
- benzinga.com Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on…
- benzinga.com What Does Atento's Debt Look Like? Over the past three months, shares of Atento Inc. (NYSE:ATTO) rose by 3.40%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its…
- benzinga.com Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
- benzinga.com Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
- benzinga.com Earnings Scheduled For November 15, 2022 Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 507 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 191 stocks hit new 52-week lows.